NCT01142947View on ClinicalTrials.gov

Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE)

NACompletedINTERVENTIONAL
Enrollment

362

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

February 28, 2017

Study Completion Date

March 11, 2019

Conditions
Asthma
Interventions
DRUG

beclomethasone dipropionate

160 mcg twice a day (320 mcg per day total)

Trial Locations (1)

48202

Henry Ford Health System, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER

NCT01142947 - Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE) | Biotech Hunter | Biotech Hunter